Literature DB >> 15673804

The new beta-lactamases.

George A Jacoby1, Luisa Silvia Munoz-Price.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15673804     DOI: 10.1056/NEJMra041359

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  197 in total

1.  Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines.

Authors:  Claude Mambo Muvunyi; Florence Masaisa; Claude Bayingana; Léon Mutesa; André Musemakweri; Grégoire Muhirwa; Geert W Claeys
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Emergence of KPC-producing Pseudomonas aeruginosa in the United States.

Authors:  Laurent Poirel; Patrice Nordmann; Emilie Lagrutta; Timothy Cleary; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

3.  High Diversity of CTX-M Extended-Spectrum β-Lactamases in Municipal Wastewater and Urban Wetlands.

Authors:  Timothy R Borgogna; Joanna-Lynn Borgogna; Jenna A Mielke; Celeste J Brown; Eva M Top; Ryan T Botts; David E Cummings
Journal:  Microb Drug Resist       Date:  2015-12-15       Impact factor: 3.431

4.  Novel Ambler class A beta-lactamase LAP-1 and its association with the plasmid-mediated quinolone resistance determinant QnrS1.

Authors:  Laurent Poirel; Vincent Cattoir; Ana Soares; Claude-James Soussy; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

5.  Molecular analysis of the simultaneous production of two SHV-type extended-spectrum beta-lactamases in a clinical isolate of Enterobacter cloacae by using single-nucleotide polymorphism genotyping.

Authors:  Dóra Szabó; Melissa A Melan; Andrea M Hujer; Robert A Bonomo; Kristine M Hujer; Christopher R Bethel; Katalin Kristóf; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology.

Authors:  Nashwan Al Naiemi; Birgitta Duim; Paul H M Savelkoul; Lodewijk Spanjaard; Evert de Jonge; Aldert Bart; Christina M Vandenbroucke-Grauls; Menno D de Jong
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

7.  Application of minimal sequence quality values prevents misidentification of the blaSHV type in single bacterial isolates carrying different SHV extended-spectrum beta-lactamase genes.

Authors:  Nashwan Al Naiemi; Kim Schipper; Birgitta Duim; Aldert Bart
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

8.  Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients With Pseudomonas aeruginosa Infection.

Authors:  Sara Y Tartof; Jennifer L Kuntz; Lie H Chen; Rong Wei; Laura Puzniak; Yun Tian; Theresa M Im; Harpreet S Takhar; Sanjay Merchant; Thomas Lodise
Journal:  JAMA Netw Open       Date:  2018-10-05

Review 9.  A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Authors:  Anne F Voor In 't Holt; Juliëtte A Severin; Emmanuel M E H Lesaffre; Margreet C Vos
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

10.  Strategic design of an effective beta-lactamase inhibitor: LN-1-255, a 6-alkylidene-2'-substituted penicillin sulfone.

Authors:  Priyaranjan Pattanaik; Christopher R Bethel; Andrea M Hujer; Kristine M Hujer; Anne M Distler; Magdalena Taracila; Vernon E Anderson; Thomas R Fritsche; Ronald N Jones; Sundar Ram Reddy Pagadala; Focco van den Akker; John D Buynak; Robert A Bonomo
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.